| 000 | 01827 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516053836.0 | ||
| 264 | 0 | _c20111214 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1939-327X | ||
| 024 | 7 |
_a10.2337/db10-0987 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKnight, Colette M | |
| 245 | 0 | 0 |
_aMediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. _h[electronic resource] |
| 260 |
_bDiabetes _c11 2011 |
||
| 300 |
_a2691-700 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aEnzyme Activators _xadministration & dosage |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aHypothalamus, Middle _xdrug effects |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 |
_aInsulin Antagonists _xpharmacology |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aKATP Channels _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aRNA, Small Interfering |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aResveratrol |
| 650 | 0 | 4 |
_aSirtuin 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStilbenes _xadministration & dosage |
| 700 | 1 | _aGutierrez-Juarez, Roger | |
| 700 | 1 | _aLam, Tony K T | |
| 700 | 1 | _aArrieta-Cruz, Isabel | |
| 700 | 1 | _aHuang, Loli | |
| 700 | 1 | _aSchwartz, Gary | |
| 700 | 1 | _aBarzilai, Nir | |
| 700 | 1 | _aRossetti, Luciano | |
| 773 | 0 |
_tDiabetes _gvol. 60 _gno. 11 _gp. 2691-700 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/db10-0987 _zAvailable from publisher's website |
| 999 |
_c21137449 _d21137449 |
||